Brain tumors and neuro-oncology focus on the diagnosis, treatment, and management of tumors affecting the central nervous system, including gliomas, meningiomas, and metastatic brain tumors. Researchers are advancing our understanding of the molecular and genetic factors driving tumor growth and resistance to therapy. Targeted therapies, such as immunotherapy and gene editing, offer new avenues for treating these aggressive conditions. Neuro-oncology also emphasizes the integration of advanced imaging techniques, such as functional MRI and PET scans, to accurately localize tumors and guide surgical intervention. As personalized medicine continues to evolve, the field aims to offer more precise and effective treatments, ultimately improving survival rates and quality of life for patients with brain tumors. The role of novel biomarkers is also gaining attention, enabling earlier detection and tailored therapeutic strategies.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom